The store will not work correctly when cookies are disabled.
4-(2-Aminopyrimidin-4-yl)-2-cyclopentylbenzoic Acid
ID: ALA4857601
PubChem CID: 164612452
Max Phase: Preclinical
Molecular Formula: C16H17N3O2
Molecular Weight: 283.33
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nccc(-c2ccc(C(=O)O)c(C3CCCC3)c2)n1
Standard InChI: InChI=1S/C16H17N3O2/c17-16-18-8-7-14(19-16)11-5-6-12(15(20)21)13(9-11)10-3-1-2-4-10/h5-10H,1-4H2,(H,20,21)(H2,17,18,19)
Standard InChI Key: UHNUJIBUPPPFFF-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
10.3337 -23.2684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0488 -22.8623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0514 -22.0419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3398 -21.6267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6240 -22.0378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6249 -22.8569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3450 -20.8043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0579 -20.3967 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6334 -20.3909 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.7583 -21.6329 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5084 -21.9715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0621 -21.3656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6557 -20.6520 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8517 -20.8194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3318 -24.0849 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6168 -24.4910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6102 -25.3126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3218 -25.7278 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0348 -24.4951 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0400 -25.3128 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7491 -25.7190 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 1 0
7 9 2 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 10 1 0
3 10 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 20 1 0
19 15 1 0
1 15 1 0
19 20 2 0
20 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 283.33 | Molecular Weight (Monoisotopic): 283.1321 | AlogP: 3.08 | #Rotatable Bonds: 3 |
Polar Surface Area: 89.10 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.67 | CX Basic pKa: 5.21 | CX LogP: 2.08 | CX LogD: 0.13 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.90 | Np Likeness Score: -0.19 |
References
1. Eduful BJ, O'Byrne SN, Temme L, Asquith CRM, Liang Y, Picado A, Pilotte JR, Hossain MA, Wells CI, Zuercher WJ, Catta-Preta CMC, Zonzini Ramos P, Santiago AS, Couñago RM, Langendorf CG, Nay K, Oakhill JS, Pulliam TL, Lin C, Awad D, Willson TM, Frigo DE, Scott JW, Drewry DH.. (2021) Hinge Binder Scaffold Hopping Identifies Potent Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2) Inhibitor Chemotypes., 64 (15.0): [PMID:34264658] [10.1021/acs.jmedchem.0c02274] |